GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TOWA Pharmaceutical Co Ltd (FRA:6QC) » Definitions » Tangible Book per Share

TOWA Pharmaceutical Co (FRA:6QC) Tangible Book per Share : €14.30 (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is TOWA Pharmaceutical Co Tangible Book per Share?

Tangible book value per share is calculated as the total tangible equity divided by Shares Outstanding (EOP). Total tangible equity is calculated as the Total Stockholders Equity minus Preferred Stock minus Intangible Assets. TOWA Pharmaceutical Co's tangible book value per share for the quarter that ended in Sep. 2024 was €14.30.

Since intangibles such as goodwill cannot be sold when the company liquidates, tangible book value per share is considered more accurate in reflecting how much shareholders will receive when the company liquidates.


TOWA Pharmaceutical Co Tangible Book per Share Historical Data

The historical data trend for TOWA Pharmaceutical Co's Tangible Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOWA Pharmaceutical Co Tangible Book per Share Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Tangible Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.22 15.96 11.53 11.92 13.14

TOWA Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Tangible Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.32 12.84 13.14 - 14.30

Competitive Comparison of TOWA Pharmaceutical Co's Tangible Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, TOWA Pharmaceutical Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TOWA Pharmaceutical Co's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TOWA Pharmaceutical Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where TOWA Pharmaceutical Co's Price-to-Tangible-Book falls into.



TOWA Pharmaceutical Co Tangible Book per Share Calculation

TOWA Pharmaceutical Co's Tangible Book Value Per Share for the fiscal year that ended in Mar. 2024 is calculated as

Tangible Book Value per Share=(Total Stockholders Equity-Preferred Stock-Intangible Assets)/Shares Outstanding (EOP)
=(957.295-0-310.624)/49.2201
=13.14

TOWA Pharmaceutical Co's Tangible Book Value Per Share for the quarter that ended in Sep. 2024 is calculated as

Tangible Book Value per Share=(Total Stockholders Equity-Preferred Stock-Intangible Assets)/Shares Outstanding (EOP)
=(1002.821-0-298.686)/49.2271
=14.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total equity is a balance sheet item and equal to total assets less total liabilities of the company. Since intangibles such as goodwill cannot be sold when the company liquidates, tangible book value per share is considered more accurate in reflecting how much shareholders will receive when the company liquidates.


TOWA Pharmaceutical Co  (FRA:6QC) Tangible Book per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


TOWA Pharmaceutical Co Tangible Book per Share Related Terms

Thank you for viewing the detailed overview of TOWA Pharmaceutical Co's Tangible Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


TOWA Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.

TOWA Pharmaceutical Co Headlines

No Headlines